{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:07:45Z","timestamp":1778695665527,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.mehy.2016.12.012","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T09:18:37Z","timestamp":1482830317000},"page":"53-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["High-concentration topical capsaicin may abolish the clinical manifestations of allergic contact dermatitis by effects on induction and elicitation"],"prefix":"10.1016","volume":"99","author":[{"given":"Hjalte H.","family":"Andersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Elberling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Arendt-Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2016.12.012_b0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-0536.1999.tb06102.x","article-title":"Allergic contact dermatitis in children and adolescents","volume":"41","author":"Mortz","year":"1999","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.mehy.2016.12.012_b0010","first-page":"36","article-title":"Allergic contact dermatitis: patch testing beyond the TRUE test","volume":"3","author":"Nelson","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.mehy.2016.12.012_b0015","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jpain.2015.04.009","article-title":"Psychophysical measurements of itch and nociceptive sensations in an experimental model of allergic contact dermatitis","volume":"16","author":"Pall","year":"2015","journal-title":"J Pain"},{"key":"10.1016\/j.mehy.2016.12.012_b0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1567-5769(01)00173-4","article-title":"Allergic contact dermatitis","volume":"2","author":"Kimber","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.mehy.2016.12.012_b0025","series-title":"Fisher's contact dermatitis","author":"Rietschel","year":"2007"},{"key":"10.1016\/j.mehy.2016.12.012_b0030","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/exd.12796","article-title":"Nociceptors in the skin: fire-raisers to be kept at bay?","volume":"24","author":"Schmelz","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.mehy.2016.12.012_b0035","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/j.1398-9995.2009.02082.x","article-title":"Effector and regulatory mechanisms in allergic contact dermatitis","volume":"64","author":"Vocanson","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.mehy.2016.12.012_b0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/cod.12311","article-title":"New concepts in cutaneous allergy","volume":"72","author":"Martin","year":"2015","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.mehy.2016.12.012_b0045","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/1523-1747.ep12874621","article-title":"Tachykinins and calcitonin gene-related peptide in oxazolone-induced allergic contact dermatitis in mice","volume":"94","author":"Ek","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2016.12.012_b0050","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/sj.jid.5700429","article-title":"Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance","volume":"126","author":"Peters","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2016.12.012_b0055","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.4049\/jimmunol.148.11.3498","article-title":"Substance P enhances IL-2 expression in activated human T cells","volume":"148","author":"Calvo","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2016.12.012_b0060","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/exd.12717","article-title":"Substance P activates human eosinophils","volume":"24","author":"Raap","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.mehy.2016.12.012_b0065","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/all.12488","article-title":"Contact sensitizer 2,4-dinitrochlorobenzene is a highly potent human TRPA1 agonist","volume":"69","author":"Saarnilehto","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.mehy.2016.12.012_b0070","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s004030050309","article-title":"Effect of topical capsaicin on the cutaneous reactions and itching to histamine in atopic eczema compared to healthy skin","volume":"290","author":"Weisshaar","year":"1998","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.mehy.2016.12.012_b0075","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1517\/14656566.2010.484420","article-title":"Therapy of pruritus","volume":"11","author":"Patel","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.mehy.2016.12.012_b0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ejp.768","article-title":"Pruritus in psoriasis: an update","volume":"20","author":"Szepietowski","year":"2016","journal-title":"Eur J Pain"},{"issue":"Suppl. 2","key":"10.1016\/j.mehy.2016.12.012_b0085","article-title":"Psoriasis pathophysiology: current concepts of pathogenesis","volume":"64","author":"Krueger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.mehy.2016.12.012_b0090","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0079-6123(03)46027-5","article-title":"Role of NGF and neurogenic inflammation in the pathogenesis of psoriasis","volume":"146","author":"Raychaudhuri","year":"2004","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.mehy.2016.12.012_b0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(97)00494-1","article-title":"Plasma extravasation and neuropeptide release in human skin as measured by intradermal microdialysis","volume":"230","author":"Schmelz","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2016.12.012_b0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neulet.2008.03.081","article-title":"Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS)","volume":"437","author":"Birklein","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2016.12.012_b0105","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0022-3565(24)37703-1","article-title":"Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice","volume":"286","author":"Andoh","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mehy.2016.12.012_b0110","series-title":"Neuroimmunology of the skin: basic science to clinical practice","author":"Granstein","year":"2009"},{"key":"10.1016\/j.mehy.2016.12.012_b0115","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/exd.12798","article-title":"Self-maintenance of neurogenic inflammation contributes to a vicious cycle in skin","volume":"24","author":"Gouin","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.mehy.2016.12.012_b0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2133.2002.04803.x","article-title":"Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis","volume":"147","author":"Toyoda","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mehy.2016.12.012_b0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-0536.2000.042001018.x","article-title":"Antigen-presenting cells and keratinocytes express interleukin-12 in allergic contact dermatitis","volume":"42","author":"Yawalkar","year":"2000","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.mehy.2016.12.012_b0130","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.4049\/jimmunol.156.5.1799","article-title":"Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance","volume":"156","author":"Riemann","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2016.12.012_b0135","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1172\/JCI117528","article-title":"Identification and induction of human keratinocyte-derived IL-12","volume":"94","author":"M\u00fcller","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2016.12.012_b0140","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/bja\/aer260","article-title":"Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch","volume":"107","author":"Anand","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.mehy.2016.12.012_b0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-0625.2011.01433.x","article-title":"Anti pruritic effects of topical crotamiton, capsaicin, and a corticosteroid on pruritogen-induced scratching behavior","volume":"21","author":"Sekine","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.mehy.2016.12.012_b0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2567.2005.02223.x","article-title":"Without nerves, immunology remains incomplete -in vivo veritas","volume":"116","author":"Shepherd","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.mehy.2016.12.012_b0155","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2567.2004.01786.x","article-title":"Nerve fibres are required to evoke a contact sensitivity response in mice","volume":"111","author":"Beresford","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.mehy.2016.12.012_b0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jneuroim.2005.04.008","article-title":"Mobilisation of specific T cells from lymph nodes in contact sensitivity requires substance P","volume":"164","author":"Shepherd","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2016.12.012_b0165","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1365-2133.1999.02908.x","article-title":"Cellular changes in denervated tissue during wound healing in a rat model","volume":"140","author":"Richards","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mehy.2016.12.012_b0170","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(05)63391-0","article-title":"Neural innervation and healing","volume":"350","author":"Richards","year":"1997","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.mehy.2016.12.012_b0175","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/1523-1747.ep12470630","article-title":"Neuropeptides enhance irritant and allergic contact dermatitis","volume":"96","author":"Gutwald","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2016.12.012_b0180","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00402226","article-title":"Substance P and calcitonin gene-related peptide modulate leukocyte infiltration to mouse skin during allergic contact dermatitis","volume":"286","author":"Goebeler","year":"1994","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.mehy.2016.12.012_b0185","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1523-1747.1999.00534.x","article-title":"A substance p agonist acts as an adjuvant to promote hapten-specific skin immunity","volume":"112","author":"Niizeki","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2016.12.012_b0190","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/brain\/awv108","article-title":"Capsaicin-sensitive C- and A-fibre nociceptors control long-term potentiation-like pain amplification in humans","volume":"138","author":"Henrich","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.mehy.2016.12.012_b9000","unstructured":"Andersen HH, Marker JB, Hoeck EA, Elberling J, Arendt-Nielsen L. Antipruritic effect of pretreatment with 8% topical capsaicin on histamine- and cowhage-evoked itch in healthy volunteers \u2013 a randomized placebo-blinded proof-of-concept trial. Br J Dermatol (in press)."}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716304674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716304674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T22:22:57Z","timestamp":1749853377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987716304674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":39,"alternative-id":["S0306987716304674"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2016.12.012","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-concentration topical capsaicin may abolish the clinical manifestations of allergic contact dermatitis by effects on induction and elicitation","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2016.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}